Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9037451rdf:typepubmed:Citationlld:pubmed
pubmed-article:9037451lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C0024264lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C0012860lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C0010858lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C1511790lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C1521828lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:9037451lifeskim:mentionsumls-concept:C1883709lld:lifeskim
pubmed-article:9037451pubmed:issue1lld:pubmed
pubmed-article:9037451pubmed:dateCreated1997-4-1lld:pubmed
pubmed-article:9037451pubmed:abstractTextThe DNA damaging effect of different concentrations of methotrexate, 6-mercaptopurine, 6-thioguanine and cisplatin was tested by nucleoid sedimentation in pokeweed mitogen (PWM)-stimulated lymphocytes of 16 healthy persons in vitro. The examined persons show an individual variation of DNA damage demonstrating individual differences in DNA repair. The method can be used to identify persons with a low DNA repair capacity, and possible cytogenetic side effects of cytostatic drugs can be calculated before starting a cancer therapy. In clinical practice the use of cytostatic drugs is limited because of the side effects on normal tissues. The cancer therapist can improve a cytostatic therapy when he obtains information about possible DNA damage of cytostatic drugs in cells of the patient at the beginning of the therapy.lld:pubmed
pubmed-article:9037451pubmed:languageenglld:pubmed
pubmed-article:9037451pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9037451pubmed:citationSubsetIMlld:pubmed
pubmed-article:9037451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9037451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9037451pubmed:statusMEDLINElld:pubmed
pubmed-article:9037451pubmed:monthJanlld:pubmed
pubmed-article:9037451pubmed:issn0004-4172lld:pubmed
pubmed-article:9037451pubmed:authorpubmed-author:FritschGGlld:pubmed
pubmed-article:9037451pubmed:authorpubmed-author:LöberGGlld:pubmed
pubmed-article:9037451pubmed:authorpubmed-author:ReitzMMlld:pubmed
pubmed-article:9037451pubmed:authorpubmed-author:GutjahrPPlld:pubmed
pubmed-article:9037451pubmed:issnTypePrintlld:pubmed
pubmed-article:9037451pubmed:volume47lld:pubmed
pubmed-article:9037451pubmed:ownerNLMlld:pubmed
pubmed-article:9037451pubmed:authorsCompleteYlld:pubmed
pubmed-article:9037451pubmed:pagination88-91lld:pubmed
pubmed-article:9037451pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:meshHeadingpubmed-meshheading:9037451-...lld:pubmed
pubmed-article:9037451pubmed:year1997lld:pubmed
pubmed-article:9037451pubmed:articleTitleDetection of DNA damage in stimulated human lymphocytes after adding cytostatic drugs in vitro. A model to demonstrate individual damage rates.lld:pubmed
pubmed-article:9037451pubmed:affiliationClinic of Anesthesiology, University of Mainz, Germany.lld:pubmed
pubmed-article:9037451pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9037451pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:9037451pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed